How Big a Deal Are the Changes to China’s One-Child Policy?
        
            By Joshua Keating, 
                Slate
             | 11. 15. 2013
        
                    
                                    
                    
                                                                                                                                    
                                                                            
                              
    
  
  
    
  
          
  
      
    
            Give the Chinese Communist Party’s Central Committee credit for unpredictability. 
All the signals sent out before this week’s highly-anticipated third plenary were that reforms on political rights were unlikely but that something significant might be in the works on China’s economic “reform and opening up.” Instead, the 
economic measures announced—particularly on the 
all-important issue of land reform—have 
been vague and difficult to parse. But the government 
has announced some significant measures on personal freedoms, including abolishing “reeducation through labor” camps, reducing land confiscations, reducing the number of crimes eligible for the death penalty, and—in what will be the most publicly scrutinized move—
easing the notorious “one child policy.”Under the new system, couples will be allowed to have a second baby if either parent is an only child—a significant slice of the population given that the policy has been in place since 1980. This isn’t quite as dramatic a change as it sounds. China has been gradually adding exceptions to the rule for years amid concerns about the country’s aging workforce.
In rural areas, couples were already...
 
 
  
 
    
    
  
   
                        
                                                                                
                 
                                                    
                            
                                  
    
  
  
      Related Articles
    
  
          
  
  
  
  
  
  
      
            
                  
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Emma Belmonte,  ChinaFile | 10.03.2025
                                                        
     
    
    
            
On the popular Chinese social media platform Xiaohongshu, also known as RedNote, an account called “Georgia Notes” (@格鲁吉亚小纸条) offers tips and advice to Chinese nationals planning a trip to the Republic of Georgia. In one post...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Karin Hammarberg, Alex Polyakov, Catherine Mills, and Karinne Ludlow,  The Conversation | 10.03.2025
                                                        
     
    
    
            Reports of several cases of embryo and sperm mix-ups have put the Australian fertility industry in the spotlight for all the wrong reasons.
These bungles have raised serious questions about the industry’s current model of self-regulation, and demonstrate a lack...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Jared Whitlock,  Endpoints News | 10.09.2025
                                                        
     
    
    
            When Nirnay Murthy learned about a treatment for his toddler son’s rare condition, relief quickly gave way to disappointment.
A one-time gene therapy called Zolgensma from the Swiss drugmaker Novartis can halt spinal muscular atrophy, a deadly condition that causes...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Karin Hammarberg and Catherine Mills,  BioNews | 10.13.2025
                                                        
     
    
    
            
The Australian fertility industry has been rocked by several recent cases of embryo and sperm mix-ups. With a lack of transparency about what clinics do to prevent such errors recurring, trust and confidence in the industry and how it is...